Related Experiment Video
Updated: May 6, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
De novo mutations in hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS)
Kathrin N Karle1, Saskia Biskup, Rebecca Schüle
1From the Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research and Department of Neurology (K.N.K., S.B., R.S., K.J.S., R.K., L.S.), Institute of Medical Genetics and Applied Genomics (P.B.), and Department of Diagnostic and Interventional Neuroradiology (B.B., T.N.), Eberhard Karls-University Tübingen; German Research Center for Neurodegenerative Diseases (K.N.K., S.B., R.S., R.K., L.S.), Tübingen; and CeGaT GmbH (S.B.), Center for Genomics and Transcriptomics, Tübingen, Germany.
Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS) is linked to CSF1R gene mutations. The study found de novo mutations and reduced penetrance, impacting genetic counseling for at-risk individuals.
Area of Science:
- Neurogenetics
- Neuroimaging
Background:
- Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS) is an autosomal dominant disorder.
- It is caused by mutations in the colony-stimulating factor 1 receptor (CSF1R) gene.
- HDLS leads to progressive cognitive and motor decline.
Observation:
- Genetic confirmation of HDLS in 6 of 25 patients with adult-onset leukoencephalopathy.
- Clinical presentation included dementia, apraxia, and extrapyramidal signs.
- Early white matter MRI changes were observed.
Findings:
- De novo CSF1R mutations were identified in one-third of patients.
- Reduced penetrance of CSF1R mutations was observed in one family.
- Family history was negative in most index patients.
Implications:
- Early clinical and MRI findings aid HDLS diagnosis.
- Consider HDLS even without a family history due to de novo mutations.
- Findings impact genetic counseling for asymptomatic carriers and suggest research into disease modifiers.
More Related Videos
11:12Assay Development for High Content Quantification of Sod1 Mutant Protein Aggregate Formation in Living Cells
Published on: October 4, 2017
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
Huntington Disease l: Introduction
Lysosomal Hydrolases